TL1A was capable of acting on RA FLS to increase the expression of IL-6, which promoted the production of Th17.
TL1A could influence RA FLS through binding to TNFR2 rather than DR3 on FLS.
TL1A increased the production of IL-6 by RA FLS possibly via NF-κB and JNK signaling pathway.
20">TL1A could promote RA FLS to secrete some immune molecules associated with inflammation and autoimmune diseases.